Novo CEO pressed by Senate to cut selling prices of being overweight, diabetes medications CEO Lars Fruergaard Jørgensen instructed lawmakers the company would take into account new talks with insurers with regard to the list costs of Wegovy and copyright whenever they pledge to maintain the medicines on their own https://busch-light-peach-nutriti16161.thenerdsblog.com/36285710/everything-about-healthcare-news